These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29113192)

  • 1. miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.
    Jin L; Li Y; Zhang Z; He T; Hu J; Liu J; Chen M; Gui Y; Yang S; Mao X; Chen Y; Lai Y
    Oncol Lett; 2017 Nov; 14(5):5624-5630. PubMed ID: 29113192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-514a-3p inhibits cell proliferation and epithelial-mesenchymal transition by targeting EGFR in clear cell renal cell carcinoma.
    Ke X; Zeng X; Wei X; Shen Y; Gan J; Tang H; Hu Z
    Am J Transl Res; 2017; 9(12):5332-5346. PubMed ID: 29312487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Li Y; Chen D; Jin LU; Liu J; Li Y; Su Z; Qi Z; Shi M; Jiang Z; Yang S; Gui Y; Mao X; Wu X; Lai Y
    Oncol Lett; 2016 Feb; 11(2):1235-1241. PubMed ID: 26893725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma.
    Chen P; Pan X; Zhao L; Jin L; Lin C; Quan J; He T; Zhou L; Wu X; Wang Y; Ni L; Yang S; Lai Y
    Exp Ther Med; 2018 Feb; 15(2):1686-1693. PubMed ID: 29434754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-411 functions as a tumor suppressor in renal cell cancer.
    Zhang X; Zhang M; Cheng J; Lv Z; Wang F; Cai Z
    Int J Biol Markers; 2017 Oct; 32(4):e454-e460. PubMed ID: 28708205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis.
    Jin L; Zhang Z; Li Y; He T; Hu J; Liu J; Chen M; Gui Y; Chen Y; Lai Y
    Oncol Lett; 2017 Jun; 13(6):4512-4520. PubMed ID: 28599452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.
    Chen P; Zhao L; Pan X; Jin L; Lin C; Xu W; Xu J; Guan X; Wu X; Wang Y; Yang S; Wang T; Lai Y
    Oncol Lett; 2018 Apr; 15(4):5995-6002. PubMed ID: 29556316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5.
    Zhang X; Wang C; Li H; Niu X; Liu X; Pei D; Guo X; Xu X; Li Y
    Oncotarget; 2017 Sep; 8(38):64106-64113. PubMed ID: 28969055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-338-3p targets SOX4 and inhibits cell proliferation and invasion of renal cell carcinoma.
    Tong Z; Meng X; Wang J; Wang L
    Exp Ther Med; 2017 Nov; 14(5):5200-5206. PubMed ID: 29201237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-638 acts as an oncogene and predicts poor prognosis in renal cell carcinoma.
    Pan X; He T; Peng X; Li H; Zhang F; Lai Y
    Am J Transl Res; 2020; 12(7):3645-3659. PubMed ID: 32774724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A.
    Huang X; Jia Y; Shi H; Fan H; Sun L; Zhang H; Wang Y; Chen J; Han J; Wang M; Du J; Zhang J
    Asian Biomed (Res Rev News); 2023 Jun; 17(3):124-135. PubMed ID: 37818158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Quan J; Pan X; He T; Lin C; Lai Y; Chen P; Zhang Z; Yang S; Wang T; Lai Y
    Exp Ther Med; 2018 Apr; 15(4):4019-4028. PubMed ID: 29581751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.